Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Cellular & Molecular Biology Letters

Fig. 3

From: hsa_circ_0006916 promotes hepatocellular carcinoma progression by activating the miR-337-3p/STAT3 axis

Fig. 3

MiR-337-3p is directly targeted by hsa_circ_0006916. a Location of hsa_circ_0006916 in hepatocellular carcinoma cells. b Potential targets of hsa_circ_0006916. c, d RNA pull-down assay demonstrated that miR-337-3p was highly expressed in hsa_circ_0006916 probe-biotin. e Binding sites between hsa_circ_0006916 and miR-337-3p. f miR-337-3p in hepatocellular carcinoma and adjacent normal samples. g Reduced miR-337-3p levels related to poor prognosis. h miR-337-3p mimics decreased the luciferase activity of hsa_circ_0006916-WT group. i hsa_circ_0006916 inhibition upregulated miR-337-3p in hepatocellular carcinoma cells. j Hsa_circ_0006916 and miR-337-3p levels have a negative correlation in hepatocellular carcinoma. *p < 0.05

Back to article page